Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Steris (STE)

STERIS fiscal 2025 revenue rises 6% to $5.5 billion; adjusted EPS $9.22

Positive Impact 3 of 5 earnings Written later

STERIS reported fiscal 2025 full-year revenue from continuing operations up 6% to $5.5 billion and diluted EPS from continuing operations of $6.16, up from $5.55. Fourth-quarter as reported diluted EPS slipped to $1.48 from $1.54 after a $48.2 million Illinois EO litigation settlement charge. The company also gave fiscal 2026 guidance of 6-7% revenue growth and adjusted EPS of $9.90 to $10.15.

Key points

  • Q4 fiscal 2025 revenue rose 4% to $1.5 billion; as reported diluted EPS was $1.48 versus $1.54 a year earlier
  • Full-year adjusted diluted EPS was $9.22, up from $8.20 in fiscal 2024
  • Fiscal 2026 outlook: revenue up 6-7% and adjusted EPS of $9.90 to $10.15, with tariffs estimated to reduce pre-tax profit by about $30 million
  • Free cash flow for fiscal 2025 was $787.2 million, up from $620.3 million

The filing

CompanySteris (STE)
Form8-K, current report
Filed with the SECMay 14, 2025, 4:34 PM ET
Accession number0001757898-25-000004

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 14, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.